Rapid sampling of arterial blood following intravenous infusion of thiopentone at l'ariollS speeds has demonstrated that the peak concentrations for doses given over five seconds are at least twice those for doses given over fifteen seconds. The area under the ClI/TeS and the dispersed arterial concentrations show no significant difference between injection speeds.
INTRODUCTION
Numerous papers have been written on the pharmacokinetics of thiopentone, ranging in time from that of Brodie et al. (19S0) to the recent paper of Becker (1978) . Relatively little attention has been paid, however, to the factors which influence the dispersion of an intravenous dose of thiopentone during the minute following injection. This lack of investigation is surprising in view of the high percentage of deaths attributable to anaesthesia which occur in the induction period and in which inappropriate dosage with thiopentone could be implicated (Harrison 1978) .
A study by A veling, Bradshaw and Crankshaw (1978) 
METHODS
Twelve adult mongrel dogs of either sex ranging in weight from 6.4 to 30.8 kg were anaesthetized with a dose of 300-600 mg of ketamine HCL (Parke-Davis). A dose of 2.S mg/kg thiopentone was then administered over S, 10, IS or 30 seconds into the brachial vein via a 21 G scalp vein needle. Three dogs were used for each injection rate. Arterial blood samples were drawn from a ISG cannula placed on one femoral artery. Sampling was commenced with the start of drug administration and continued at 3 second intervals, reducing to 5 second and then 10 second intervals until 40 seconds after completion of the drug infusion. 1.8 ml blood samples were collected using a B-D Cornwall Luer-Lok automatic 3/way syringe and deposited into collecting tubes containing 0.2 ml of oxalate solution (NH~Ox:1.8 g, HOx:I.2 g, H~O:SO ml).
Blood thiopentone concentrations were determined using ultraviolet spectrophotometric analysis. Thiopentone was extracted into diethyl ether using 4M NaH~POI as a buffer, and then back extracted into O.S ml of 0.2N NaOH. This process was facilitated with vortex centrifugation and freezing in an acetone/ dryice bath. Absorption was measured with a U nicam SP 1800 ultraviolet spectrophotometer and actual concentrations read from the calibration curve shown in Figure 1 
RESULTS
Calibration of the equipment using pooled dog blood resulted in the curve shown in Figure  1 . At no time did the standard error of the individual means exceed 3.5 % of value. The extraction process was able to recover 95% of the rhiopentone added to the blood .
Values for blood thiopentone concentrations following injections of 2.5 mg/kg over 5, to, 15 and 30 seconds are shown in Figure 2 . Peak concentrations in excess of 120 ,..,g/ml occurred during the 5 second infusion . Considerable variation was apparent between dogs, particularly at the shorter injection times.
In each experiment, however, arterial concentration fell to less than 10 ,..,g/ ml within 30 seconds of completion of the injection.
An analysis of peak heights of the curves in Figure 2 is shown in Figure 3 (a). The mean of the peak heights at 5 seconds is 97% greater than the mean at 15 seconds and they differ significantly (p < .02, Student's Hest). Figure 2 . A Student's Hest did not show differences between the means at any of the injection speeds at the p = 0.2 level.
Analysis of thiopentone concentrations 40 seconds after completion of the injection over 5, 10, 15 and 30 seconds showed mean concentrations of 6.5, 3.3, 6.0 and 6.0 I,g/ml respectively (see Figure 2) . No significant differences were demonstrated between these values (p ::-' 0.2).
DISCUSSION
The curves obtained have the shape that would be anticipated for the dispersion of a rapidly administered bolus into a fast moving circulation. The leading edges are steep while the tails are extended suggesting some transient uptake by the pulmonary tissues. There is little evidence of recirculation, indicating a high degree of uptake into the richly perfused tissues. Variation in the height of the peaks between dogs at the fastest infusion times could be due to differing morphology of the dogs, to the manual method of administration and also to the intermittent sampling technique, which is unlikely to select the actual peaks of the curves.
The differences in heights of the curves between injection speeds is highly significant. The twofold variation in height between infusion times of 15 and 5 seconds is considerab:y greater than might have been expected from the results of A veling et al. ( 1978) who found a 36% reduction in ED50 for the shorter infusion time. This suggests some delay in diffusion might exist between the arterial blood and the cerebral tis:ues, attenuating the effect of the peak drug levels. This could be a physical barrier, although studies by Mark et al. (1957) suggest transfer across the blood brain barrier is extremely rapid, or it could be due to some delay in release of thiopentone from the plasma proteins which bind up to 85% of the drug (Day ton el al. 1967).
The lack of variation in the area under the concentration curve between dogs suggests a fairly consistent relationship between total body weight and cardiac output. This direct relationship would be much less likely in unselected human patients for doses given on the basis of total body weight.
The dose level chosen of 2.5 mg/kg is close to the ED50 for human subjects (Crankshaw and Allt-Graham 1978) . ] t is well below anaesthetic doses for the dog, and is unlikely to have significant haemodynamic effects (Chamberlain, Seed and Chung 1977) . The effect of ketamine HCL at the dose level used is also unlikely to be marked (Horowitz 1977) .
In conclusion, it can be said that if the same dose is administered into the venous circulation at different rates, two-fold variations in peak concentration can be produced, but distributed levels are unlikely to differ. Such peaks have the potential to increase hypnotic effects and toxic side effects but the effects are likely to be very transient provided adequate circulation is maintained.
